Forma Therapeutics (FMTX) Stock Analysis
NASDAQHealthcareBiotechnology
What Forma Therapeutics does
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing groundbreaking therapies for rare hematologic conditions and various cancers. Its lead development candidates include FT-4202, undergoing Phase 1 trials for sickle cell disease and other hemoglobinopathies, and FT-7051, targeting metastatic castration-resistant prostate cancer. The company is also progressing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 (IDH1) gene mutations, currently in Phase II for relapsed/refractory acute myeloid leukemia and Phase I for glioma. Furthermore, Forma is developing FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to disrupt de novo lipogenesis in the liver. Founded in 2007 and headquartered in Watertown, Massachusetts, Forma Therapeutics Holdings, Inc. has operated as a subsidiary of Novo Nordisk A/S since October 14, 2022.
Key metrics
ETFs linked to FMTX
Broad-market and Healthcare sector ETFs an investor holding Forma Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how FMTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze FMTX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Forma Therapeutics?
- Forma Therapeutics trades under the ticker FMTX on NASDAQ.
- Which exchange is FMTX listed on?
- FMTX is listed on NASDAQ.
- What sector does Forma Therapeutics operate in?
- Forma Therapeutics is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze FMTX in a portfolio?
- PortView shows FMTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.